Genmab A (GMAB) Operating Leases (2023 - 2025)

Genmab A's Operating Leases history spans 3 years, with the latest figure at $134.0 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 2.29% year-over-year to $134.0 million; the TTM value through Dec 2025 reached $134.0 million, up 2.29%, while the annual FY2025 figure was $134.0 million, 2.29% up from the prior year.
  • Operating Leases reached $134.0 million in Q4 2025 per GMAB's latest filing, up from $131.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $134.0 million in Q4 2025 to a low of $114.0 million in Q4 2023.
  • Average Operating Leases over 3 years is $126.3 million, with a median of $131.0 million recorded in 2024.
  • Peak YoY movement for Operating Leases: grew 14.91% in 2024, then grew 2.29% in 2025.
  • A 3-year view of Operating Leases shows it stood at $114.0 million in 2023, then increased by 14.91% to $131.0 million in 2024, then rose by 2.29% to $134.0 million in 2025.
  • Per Business Quant, the three most recent readings for GMAB's Operating Leases are $134.0 million (Q4 2025), $131.0 million (Q4 2024), and $114.0 million (Q4 2023).